Terumo Corp. (OTCMKTS:TRUMY) Short Interest Up 80.3% in July

Terumo Corp. (OTCMKTS:TRUMY) saw a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 85,412 shares, a growth of 80.3% from the June 30th total of 47,370 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 287,234 shares, the days-to-cover ratio is presently 0.3 days.

Terumo Stock Up 5.8%

Terumo stock opened at $14.85 on Thursday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59. Terumo has a one year low of $12.08 and a one year high of $19.60. The company has a 50-day simple moving average of $14.01 and a 200-day simple moving average of $13.53. The firm has a market capitalization of $21.90 billion, a P/E ratio of 24.34 and a beta of 0.68.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings data on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, meeting the consensus estimate of $0.11. The firm had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.17%. As a group, equities analysts expect that Terumo will post 0.7 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Terumo to a “hold” rating in a report on Thursday, April 9th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.